SecBot SecBot
8-K ·Filed Oct 13, 2026

INBS

INTELLIGENT BIO SOLUTIONS INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed14d 5h ago SEC0001493152-26-046863
8-K context-dependent: Items 7.01
Actionable Insight • Neutral

This is a routine governance filing with no trading implications. Monitor the investor presentation on the company's website for any strategic updates, but the 8-K itself contains no actionable financial information.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
INBS ▲ +19.31% at T+5d
NEUTRAL call +19.31% · α vs SPY +18.86% · entry $1.45 → $1.73
Next anchor: T+20d in 13d
Latest observation: T+7 +18.34% FF3 residual α
Entry = T+0 close
Oct 13, 2026
via day close
T+1d
-0.69%
call -0.69% · α -0.97%
$1.44
settled 14d ago
T+5d
+19.31%
call +19.31% · α +18.86%
$1.73
settled 8d ago
T+20d
Pending
in 13d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Intelligent Bio Solutions Inc. filed an 8-K reporting the adoption of Second Amended and Restated Bylaws (effective October 12, 2026) and furnished an investor presentation via Regulation FD. The bylaw amendment clarifies that stockholder votes on matters other than director elections are decided by a majority of votes cast, excluding abstentions and broker non-votes. No financial data or material operational updates were disclosed.

Key Facts

  • Board adopted Second Amended and Restated Bylaws effective October 12, 2026.
  • Section 2.6 revised to clarify majority-of-votes-cast standard for non-director-election matters, explicitly excluding abstentions and broker non-votes.
  • Company furnished an investor presentation (Exhibit 99.1) on October 13, 2026, accessible via the Investors section of its website.
  • No financial results, guidance, or material business updates were provided in the filing.

Financial Impact

No financial impact disclosed in this filing.

Risk Factors

  • No material risks identified from this filing.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-046863
Document: form8-k.htm0001493152-26-046863
Document: 0001493152-26-046863-index-headers.html0001493152-26-046863
Document: 0001493152-26-046863-index.html0001493152-26-046863
Document: 0001493152-26-046863.txt0001493152-26-046863
17 reports for INBS
Performance horizon
80% Hit rate @ T+20 4 of 5 directional calls Went positive at some point 4 of 5 best @ T+20▲ +43.43%Jul 23, 2026
Filters
Rows
Reports for INBS — sortable, filterable
TypeNow
Oct 21, 2026
6d ago
10-K/A
NEUTRAL ★ 3/10
$1.69awaiting T+20—$1.72 (+2.08%)
Oct 13, 2026
14d ago
8-K
NEUTRAL ★ 2/10
$1.45awaiting T+20—$1.72 (+18.62%)
Sep 24, 2026
4w ago
EFFECT
BEARISH ★ 5/10
$1.71 $1.69▲ +1.46%▲ +1.04%$1.72 (−0.58%)
Sep 15, 2026
6w ago
S-3
NEUTRAL ★ 3/10
$1.97 $1.48▼ −24.87%▼ −28.05%$1.72 (−12.69%)
Sep 11, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$2.07 $1.51▼ −27.05%▼ −29.32%$1.72 (−16.91%)
Sep 9, 2026
6w ago
8-K
BULLISH ★ 6/10
$2.24 $1.59▼ −29.02%▼ −30.96%$1.72 (−23.21%)
Sep 2, 2026
7w ago
8-K
BEARISH ★ 7/10
$2.30 $1.66▲ +27.83%▲ +26.64%$1.72 (+25.22%)
Aug 19, 2026
9w ago
8-K
NEUTRAL ★ 5/10
$2.67 $2.05▼ −23.22%▼ −21.70%$1.72 (−35.58%)
Aug 19, 2026
9w ago
Press Release
BEARISH ★ 5/10
$2.67 $2.05▲ +23.22%▲ +21.70%$1.72 (+35.58%)
Aug 17, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$3.37 $2.05▼ −39.17%▼ −37.19%$1.72 (−48.96%)
Showing 10 of 17

US Market Status

Market Closed — Opens Thu (10h 49m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 13, 2026